PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China · Delayed Price · Currency is CNY 38.11
+0.61 (1.63%)
Jul 29, 2026, 3:04 PM CST
SHE:300725 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,027 | 1,974 | 1,689 | 1,725 | 1,595 | 1,202 |
Revenue Growth | 14.79% | 16.93% | -2.12% | 8.18% | 32.71% | 17.55% |
Gross Profit Gross Profit Growth | 603.12 | 577.86 | 582.74 | 707.2 | 715.99 | 568.78 |
Operating Income Operating Income Growth | 197.87 | 195.46 | 226.31 | 259.95 | 280.21 | 269.44 |
Net Income Net Income Growth | 196.83 | 183.74 | 219.54 | 197.36 | 314.22 | 486.56 |
Earnings Per Share EPS Growth | 0.91 | 0.88 | 1.10 | 0.98 | 1.57 | 2.44 |
EPS Growth | -12.07% | -20.00% | 12.25% | -37.58% | -35.66% | 148.98% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
China China Growth | 539.88 | 448.7 | 543.7 | 488.58 |
Foreign Foreign Growth | 1,435 | 1,240 | 1,182 | 1,106 |
Total Total Growth | 1,974 | 1,689 | 1,725 | 1,595 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,063 | 1,620 | 1,374 | 1,601 | 1,617 | 1,105 |
Total Debt Total Debt Growth | 112.42 | 112.67 | 1,414 | 1,749 | 1,573 | 381.02 |
Net Cash (Debt) Net Cash Growth | 950.77 | 1,507 | -39.71 | -147.83 | 44.11 | 723.78 |
Net Cash Growth | - | - | - | - | -93.91% | -42.42% |
Net Cash Per Share Net Cash Per Share Growth | 4.38 | 7.22 | -0.20 | -0.73 | 0.22 | 3.63 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 471.2 | 667.36 | 302.82 | 246.84 | 246.61 | 238.03 |
Capital Expenditures CapEx Growth | -204.52 | -140.13 | -118.12 | -315.77 | -557.91 | -505.76 |
Free Cash Flow Free Cash Flow Growth | 266.68 | 527.23 | 184.7 | -68.93 | -311.3 | -267.73 |
Free Cash Flow Growth | -28.85% | 185.45% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.75% | 29.27% | 34.51% | 40.99% | 44.90% | 47.33% |
Operating Margin | 9.76% | 9.90% | 13.40% | 15.07% | 17.57% | 22.42% |
Pretax Margin | 10.97% | 10.51% | 14.74% | 12.83% | 20.27% | 42.26% |
Profit Margin | 9.71% | 9.31% | 13.00% | 11.44% | 19.70% | 40.49% |
FCF Margin | 13.15% | 26.70% | 10.94% | -4.00% | -19.52% | -22.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.280 | 0.280 | 0.280 | 0.310 | 0.100 | 0.100 |
Dividend Per Share Growth | 0% | 0% | -9.68% | 210.00% | 0% | 30.04% |
Dividend Yield | 0.75% | 0.73% | 0.85% | 0.81% | 0.13% | 0.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 42.07 | 48.89 | 30.43 | 39.73 | 51.15 | 58.35 |
Forward PE | - | 37.71 | 26.11 | 27.44 | 37.00 | 65.42 |
P/FCF Ratio | 33.29 | 17.04 | 36.17 | - | - | - |
PS Ratio | 4.38 | 4.55 | 3.96 | 4.55 | 10.08 | 23.63 |